What is EyeControl?
EyeControl specializes in adaptive patient communication solutions designed to enhance interaction across diverse healthcare settings. Their innovative products support patients throughout their care journey, from sedation to recovery, effectively restoring their ability to communicate and actively participate in their treatment. By empowering medical teams and families with advanced tools, EyeControl facilitates more compassionate and responsive patient care, ultimately aiming to improve health outcomes and elevate the overall patient and family experience.
How much funding has EyeControl raised?
EyeControl has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2020): $10M, investors not publicly disclosed
What's next for EyeControl?
With a substantial Series A funding round, EyeControl is strategically positioned for significant scaling and further development of its adaptive communication technologies. This capital injection is expected to fuel expansion into new markets, enhance product capabilities, and strengthen strategic partnerships within the healthcare ecosystem. The company's focus on patient empowerment and improved care delivery suggests a trajectory towards becoming a leader in assistive communication for medical environments.
See full EyeControl company page
